| Onset of Alzheimer disease in apolipoprotein varepsilon4 carriers is earlier in butyrylcholinesterase K variant carriers. | Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.
Lane RM, Darreh-Shori T, Junge C, Li D, Yang Q, Edwards AL, Graham DL, Moore K, Mummery CJ., Free PMC Article | 04/24/2024 |
| Butyrylcholinesterase in lipid metabolism: A new outlook. | Butyrylcholinesterase in lipid metabolism: A new outlook.
Gok M, Cicek C, Bodur E. | 04/19/2024 |
| Butyrylcholinesterase activity in patients with postoperative delirium after cardiothoracic surgery or percutaneous valve replacement- an observational interdisciplinary cohort study. | Butyrylcholinesterase activity in patients with postoperative delirium after cardiothoracic surgery or percutaneous valve replacement- an observational interdisciplinary cohort study.
Schlake K, Teller J, Hinken L, Laser H, Lichtinghagen R, Schäfer A, Fegbeutel C, Weissenborn K, Jung C, Worthmann H, Gabriel MM., Free PMC Article | 03/5/2024 |
| Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker. | Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.
Wang S, Huang X, Zhao S, Lv J, Li Y, Wang S, Guo J, Wang Y, Wang R, Zhang M, Qiu W., Free PMC Article | 02/21/2024 |
| Human Butyrylcholinesterase Mutants for (-)-Cocaine Hydrolysis: A Correlation Relationship between Catalytic Efficiency and Total Hydrogen Bonding Energy with an Oxyanion Hole. | Human Butyrylcholinesterase Mutants for (-)-Cocaine Hydrolysis: A Correlation Relationship between Catalytic Efficiency and Total Hydrogen Bonding Energy with an Oxyanion Hole.
Zheng F, Hou S, Xue L, Yang W, Zhan CG. | 01/3/2024 |
| Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro. | Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro.
Jasiecki J, Targońska M, Janaszak-Jasiecka A, Kalinowski L, Waleron K, Wasąg B. | 11/30/2023 |
| Improving the Efficiency of Precise Genome Editing with CRISPR/Cas9 to Generate Goats Overexpressing Human Butyrylcholinesterase. | Improving the Efficiency of Precise Genome Editing with CRISPR/Cas9 to Generate Goats Overexpressing Human Butyrylcholinesterase.
Wang JH, Wu SJ, Li Y, Zhao Y, Liu ZM, Deng SL, Lian ZX., Free PMC Article | 08/14/2023 |
| Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study. | Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study.
Markuskova L, Javorova Rihova Z, Fazekas T, Martinkovicova A, Havrisko M, Dingova D, Solavova M, Rabarova D, Hrabovska A., Free PMC Article | 06/13/2023 |
| Dysregulation of butyrylcholinesterase, BCHE gene SNP rs1803274, and pro-inflammatory cytokines in occupational workers. | Dysregulation of butyrylcholinesterase, BCHE gene SNP rs1803274, and pro-inflammatory cytokines in occupational workers.
Khan SA, Leonel Javeres MN, Abbas Shah ST, Bibi N, Muneer Z, Hussain S, Nepovimova E, Kuca K, Nurulain SM. | 02/25/2023 |
| Novel activity of human BChE: Lipid hydrolysis. | Novel activity of human BChE: Lipid hydrolysis.
Gok M, Cicek C, Sari S, Bodur E. | 01/14/2023 |
| BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity. | BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J, Tian T, Liu X, Cui Z., Free PMC Article | 08/6/2022 |
| Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study. | Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study.
Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C. | 04/9/2022 |
| Genetic Association of Butyrylcholinesterase with Major Depressive Disorder. | Genetic Association of Butyrylcholinesterase with Major Depressive Disorder.
Awan S, Hashmi AN, Taj R, Munir S, Habib R, Batool S, Azam M, Qamar R, Nurulain SM. | 03/26/2022 |
| Characterization of four BCHE mutations associated with prolonged effect of suxamethonium. | Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
Brazzolotto X, Courcelle S, Sauvanet C, Guillon V, Igert A, Kononchik J, Nachon F, Ceppa F, Delacour H. | 01/15/2022 |
| Cholinesterase homozygous genotype as susceptible biomarker of hypertriglyceridaemia for pesticide-exposed agricultural workers. | Cholinesterase homozygous genotype as susceptible biomarker of hypertriglyceridaemia for pesticide-exposed agricultural workers.
Zhou X, Zhang M, Wang Y, Xia H, Zhu L, Li G, Rong L, Dong H, Chen R, Tang S, Yu M. | 11/27/2021 |
| Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase. | Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Mascarenhas AMS, de Almeida RBM, de Araujo Neto MF, Mendes GO, da Cruz JN, Dos Santos CBR, Botura MB, Leite FHA. | 10/23/2021 |
| Bio-Guided Fractionation of Stem Bark Extracts from Phyllanthus muellarianus: Identification of Phytocomponents with Anti-Cholinesterase Activity. | Bio-Guided Fractionation of Stem Bark Extracts from Phyllanthus muellarianus: Identification of Phytocomponents with Anti-Cholinesterase Activity.
Naldi M, Brusotti G, Massolini G, Andrisano V, Temporini C, Bartolini M., Free PMC Article | 09/18/2021 |
| Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists. | Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists.
Konecny J, Misiachna A, Hrabinova M, Pulkrabkova L, Benkova M, Prchal L, Kucera T, Kobrlova T, Finger V, Kolcheva M, Kortus S, Jun D, Valko M, Horak M, Soukup O, Korabecny J., Free PMC Article | 06/26/2021 |
| SNPs from BCHE and DRD3 genes associated to cocaine abuse amongst violent individuals from Sao Paulo, Brazil. | SNPs from BCHE and DRD3 genes associated to cocaine abuse amongst violent individuals from Sao Paulo, Brazil.
Pego AMF, Leyton V, Miziara ID, Bortolin RH, Freitas RCC, Hirata M, Tomaz PRX, Santos JR, Santos PCJL, Yonamine M. | 05/15/2021 |
| Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study. | Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF, Varma V, An Y, Tanaka T, Davatzikos C, Resnick SM, Thambisetty M., Free PMC Article | 05/15/2021 |
| Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from Glycyrrhiza uralensis. | Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from Glycyrrhiza uralensis.
Jeong GS, Kang MG, Lee JY, Lee SR, Park D, Cho M, Kim H., Free PMC Article | 03/13/2021 |
| Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients. | Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients.
Campello AC, Zanella LGFABDE, Suzuki RB, Tokumo MO, Chagas EFB, Baleotti W, Sperança MA, Martins LPA. | 11/28/2020 |
| Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. | Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Jasiecki J, Limon-Sztencel A, Żuk M, Chmara M, Cysewski D, Limon J, Wasąg B., Free PMC Article | 10/3/2020 |
| Lower plasma acetylcholinesterase and butyrylcholinesterase activity were independent risk factors for postoperative delirium. | Low Plasma Cholinesterase Activity is Associated With Postoperative Delirium After Noncardiac Surgery in Elderly Patients: AProspective Observational Study.
Zhao B, Ni Y, Tian X. | 12/14/2019 |
| Results found that the SNP rs1803274, defining K-variant BCHE, interacted significantly with pesticide exposure and increased the risk of Parkinson's disease (PD) only in pesticide-exposed patients. The K-variant BCHE reduces serum activity of butyrylcholinesterase, a known bioscavenger for pesticides. These results suggest that K-variant BCHE appear to have an increased risk for PD after exposition to pesticides. | K-variant BCHE and pesticide exposure: Gene-environment interactions in a case-control study of Parkinson's disease in Egypt.
Rösler TW, Salama M, Shalash AS, Khedr EM, El-Tantawy A, Fawi G, El-Motayam A, El-Seidy E, El-Sherif M, El-Gamal M, Moharram M, El-Kattan M, Abdel-Naby M, Ashour S, Müller U, Dempfle A, Kuhlenbäumer G, Höglinger GU., Free PMC Article | 12/7/2019 |